You may be eligible if you: Have a BMI over 30, or over 27 with weight-related health concerns Struggle with appetite control or weight loss despite lifestyle changes Are not currently pregnant or breastfeeding Have not had bariatric surgery within the last 18 months Do not have a history of contraindicated conditions such as pancreatitis, medullary thyroid cancer, pancreatitis, or MEN syndrome, or certain kinds of endocrine cancers Are committed to monthly check-ins and physician-guided care *During your consultation, a medical provider will review your health history, lab work, and goals to determine your eligibility for GLP-1 treatment for weight loss
Regular health checkups and routine lab tests are vital in assessing these parameters and tracking the medications effectiveness over time
Various pre-clinical and phase-2 studies have indicated the therapeutic potential of semaglutide in non-alcoholic steatohepatitis and neurodegenerative disorders like Parkinsons and Alzheimers disease
This effect arises from appetite suppression, increased fullness, and slower stomach emptying, which makes it easier to reduce caloric intake sustainably
Accessible Care: Microdosing offers a thoughtful, lower-intensity option for those seeking a monitored and guided protocol
Missing two or more consecutive weeks resets your GLP-1 tolerance
